About Arylsulfatase B
Arylsulfatase B (ARSB) is a protein
from Homo sapiens identified by UniProt accession
P15848, 533 residues long.
MolForge cross-references it against 0 known binders and
272 disease associations.
Target properties
| Protein name | Arylsulfatase B |
| UniProt accession | P15848 |
| Gene | ARSB |
| Organism | Homo sapiens |
| Length | 533 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (272)
Diseases linked to this target (Open Targets).
- mucopolysaccharidosis type 6 · score 0.88
- mucopolysaccharidosis · score 0.58
- metachromatic leukodystrophy · score 0.48
- genetic disorder · score 0.45
- heel bone mineral density · score 0.41
- arylsulfatase B measurement · score 0.39
- monocyte count · score 0.38
- Multiple sulfatase deficiency · score 0.37
- mucosulfatidosis · score 0.37
- mucopolysaccharidosis type 6, slowly progressing · score 0.37
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P15848-F1 | alphafold | PREDICTED | 93.10 | — |
Amino-acid sequence (533 residues)
MGPRGAASLP RGPGPRRLLL PVVLPLLLLL LLAPPGSGAG ASRPPHLVFL LADDLGWNDV GFHGSRIRTP HLDALAAGGV LLDNYYTQPL CTPSRSQLLT GRYQIRTGLQ HQIIWPCQPS CVPLDEKLLP QLLKEAGYTT HMVGKWHLGM YRKECLPTRR GFDTYFGYLL GSEDYYSHER CTLIDALNVT RCALDFRDGE EVATGYKNMY STNIFTKRAI ALITNHPPEK PLFLYLALQS VHEPLQVPEE YLKPYDFIQD KNRHHYAGMV SLMDEAVGNV TAALKSSGLW NNTVFIFSTD NGGQTLAGGN NWPLRGRKWS LWEGGVRGVG FVASPLLKQK GVKNRELIHI SDWLPTLVKL ARGHTNGTKP LDGFDVWKTI SEGSPSPRIE LLHNIDPNFV DSSPCPRNSM APAKDDSSLP EYSAFNTSVH AAIRHGNWKL LTGYPGCGYW FPPPSQYNVS EIPSSDPPTK TLWLFDIDRD PEERHDLSRE YPHIVTKLLS RLQFYHKHSV PVYFPAQDPR CDPKATGVWG PWM
Explore Arylsulfatase B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets